Literature DB >> 29024354

Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.

Chutimon Muankaew1, Thorsteinn Loftsson2.   

Abstract

Cyclodextrins (CDs) are recognized as promising pharmaceutical excipients due to their unique ability to form water-soluble inclusion complexes with various poorly soluble compounds. The numerous investigations on CDs and their use in nanomedicine have received considerable attention in the last three decades, leading to the rapid development of new CD-containing formulations that significantly facilitate targeted drug delivery and controlled drug release, with consequent improvements in drug bioavailability. This MiniReview highlights the efficacy and recent uses of CDs for non-invasive drug delivery. Using ophthalmic and nasal drug delivery as examples, an overview of chemical properties, mechanisms of CDs on drug solubilization, stabilization and permeation, along with their toxicological profiles relevant to nasal and ocular administration, are provided and discussed. The recent development and application of CD-based nanocarrier systems for targeted drug delivery are summarized.
© 2017 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29024354     DOI: 10.1111/bcpt.12917

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  21 in total

Review 1.  Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies.

Authors:  Ana Cláudia Santos; Diana Costa; Laura Ferreira; Catarina Guerra; Miguel Pereira-Silva; Irina Pereira; Diana Peixoto; Nuno R Ferreira; Francisco Veiga
Journal:  Drug Deliv Transl Res       Date:  2021-02       Impact factor: 4.617

2.  Cyclodextrins in drug delivery: applications in gene and combination therapy.

Authors:  Rebecca M Haley; Riccardo Gottardi; Robert Langer; Michael J Mitchell
Journal:  Drug Deliv Transl Res       Date:  2020-06       Impact factor: 4.617

3.  Effect of Cyclodextrins on the Biofilm Formation Capacity of Pseudomonas aeruginosa PAO1.

Authors:  Zsófia Berkl; Ildikó Fekete-Kertész; Kata Buda; Emese Vaszita; Éva Fenyvesi; Lajos Szente; Mónika Molnár
Journal:  Molecules       Date:  2022-06-03       Impact factor: 4.927

4.  Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles.

Authors:  Leon J Khoza; Pradeep Kumar; Admire Dube; Patrick H Demana; Yahya E Choonara
Journal:  Int J Pharm       Date:  2022-06-06       Impact factor: 6.510

5.  Differential gene expression and gene-set enrichment analysis in Caco-2 monolayers during a 30-day timeline with Dexamethasone exposure.

Authors:  J M Robinson; S Turkington; S A Abey; N Kenea; W A Henderson
Journal:  Tissue Barriers       Date:  2019-08-22

6.  Investigation of Combined Cyclodextrin and Hydrogel Formulation for Ocular Delivery of Dexamethasone Acetate by Means of Experimental Designs.

Authors:  Roseline Mazet; Luc Choisnard; Delphine Levilly; Denis Wouessidjewe; Annabelle Gèze
Journal:  Pharmaceutics       Date:  2018-12-01       Impact factor: 6.321

Review 7.  Cyclodextrin-Based Contrast Agents for Medical Imaging.

Authors:  Yurii Shepelytskyi; Camryn J Newman; Vira Grynko; Lauren E Seveney; Brenton DeBoef; Francis T Hane; Mitchell S Albert
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

8.  Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7.

Authors:  Abdelhamid Nacereddine; Andre Bollacke; Eszter Róka; Christelle Marminon; Zouhair Bouaziz; Ferenc Fenyvesi; Ildikó Katalin Bácskay; Joachim Jose; Florent Perret; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2018-01-26

Review 9.  Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes.

Authors:  Phennapha Saokham; Chutimon Muankaew; Phatsawee Jansook; Thorsteinn Loftsson
Journal:  Molecules       Date:  2018-05-11       Impact factor: 4.411

Review 10.  Nanoscale Self-Assembly for Therapeutic Delivery.

Authors:  Santosh Yadav; Ashwani Kumar Sharma; Pradeep Kumar
Journal:  Front Bioeng Biotechnol       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.